Specialty Dosage Drugs

Jan 05, 2016
By Pharmaceutical Technology Editors
Ionis Pharmaceuticals receives orphan drug designation for HTTRx for the treatment of Huntington’s disease.
Oct 06, 2015
By Pharmaceutical Technology Editors
3M and Impel will collaborate to develop and commercialize Impel’s Precision Olfactory Delivery technology for enhanced central nervous system drug delivery.
Sep 08, 2015
By Pharmaceutical Technology Editors
The agency has set up a workshop on how to demonstrate the benefits of orphan drugs over existing treatments.
Sep 02, 2015
Pharmaceutical Technology
Current guidance for absorption of elemental impurities does not address dermal exposure, resulting in a simplistic approach to limit setting; available information shows that exposure to low-level elemental impurities is unlikely to be a substantive concern for topical drug products.
Jun 02, 2015
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Pharmaceutical Technology spoke with David Fitzhenry about the costs of specialty drugs.
Jun 02, 2015
Pharmaceutical Technology
Successful drug delivery via a dry powder inhaler is determined by the API physicochemical properties, the formulation composition and process, the device and operating conditions, the patient–device relationship, the environmental variables, and ultimately, patient compliance.
May 28, 2015
By Pharmaceutical Technology Editors
Experts attending the European Psychiatry Association Congress in Vienna say that Adasuve has made an impact in the treatment of agitation in patients suffering from schizophrenia or bipolar I disorder.
May 21, 2015
CVS Health signed a definitive agreement to acquire Omnicare for $12.7 billion to expand its reach to assisted living and long-term care facilities.
May 04, 2015
Pharmaceutical Technology
Advances in transdermal drug delivery, particularly with microneedles, are enabling a wider range of drugs to be delivered through the skin.
Apr 24, 2015
By Pharmaceutical Technology Editors
Dicerna Pharmaceuticals announces that FDA granted its primary hyperoxaluria type 1 (PH1) treatment Orphan Drug designation.
native1_300x100
lorem ipsum